Clinical trials
Phase 2 COVID-19 trials in Brazil
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
53 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2018 | 1 |
| 2020 | 30 |
| 2021 | 17 |
| 2022 | 4 |
| 2023 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 30 |
| Terminated | 12 |
| Unknown status | 9 |
| Recruiting | 2 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Fundação de Medicina Tropical Dr. Heitor Vieira Dourado | 3 |
| Universidade Federal do Rio de Janeiro | 3 |
| D'Or Institute for Research and Education | 2 |
| Hospital do Coracao | 2 |
| Sorrento Therapeutics, Inc. | 2 |
| University of Sao Paulo General Hospital | 2 |
| Andrew Eisenberger | 1 |
| Angion Biomedica Corp | 1 |
| AstraZeneca | 1 |
| Atea Pharmaceuticals, Inc. | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| COVID-19 | 53 |
| Coronavirus Infections | 12 |
| Pneumonia | 6 |
| Severe Acute Respiratory Syndrome | 4 |
| Respiratory Distress Syndrome | 3 |
| Respiratory Insufficiency | 3 |
| Acute Lung Injury | 2 |
| Cytokine Release Syndrome | 2 |
| Post-Acute COVID-19 Syndrome | 2 |
| Anemia, Sickle Cell | 1 |
Trials
Showing 1 to 25 of 53. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.